VALBIOTIS (EPA:ALVAL) | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
VALBIOTIS

BRIEF

published on 11/20/2024 at 11:55, 23 hours 5 minutes ago

VALBIOTIS SA: Monthly update on the capital structure

Share Capital Voting Rights Euronext Growth Valbiotis Financial Regulations
BRIEF

published on 11/20/2024 at 11:54, 23 hours 5 minutes ago

VALBIOTIS SA: Update on voting rights and shares

Voting Rights Actions Euronext Growth Valbiotis Crossing Thresholds
BRIEF

published on 11/06/2024 at 17:45, 14 days 17 hours ago

VALBIOTIS launches Valbiotis®PRO for the prevention of metabolic diseases

Valbiotis Metabolic Health TOTUM•63 Diabetes Prevention Marketing France
PRESS RELEASE

published on 11/06/2024 at 17:40, 14 days 17 hours ago

VALBIOTIS to launch Valbiotis®PRO Metabolic Health (Totum•63) for the prevention of metabolic diseases on the French market in February-March 2025.
Valbiotis announces the launch of Valbiotis®PRO Metabolic Health (Totum•63) on the French market in February-March 2025, addressing metabolic diseases preventively

Valbiotis Prevention French Market Metabolic Health TOTUM•63
BRIEF

published on 11/05/2024 at 18:05, 15 days 16 hours ago

Valbiotis approves share buyback program at General Meeting

Share Buyback Valbiotis General Assembly Food Supplements Resolutions Voted
BRIEF

published on 10/29/2024 at 17:45, 22 days 17 hours ago

Valbiotis Reports H1 2024 Financial Results and Strategic Developments

Valbiotis Product Launch Strategic Roadmap Interim Financials Scientific Results
PRESS RELEASE

published on 10/29/2024 at 17:40, 22 days 17 hours ago

VALBIOTIS publishes its interim financial statements
Valbiotis publishes interim financial statements for H1 2024 showing a cash position of €18.5M and confirming its commercial roadmap. Key events review the successful launch of Valbiotis@PRO Cholesterol

Cash Position Valbiotis Product Launch Interim Financial Statements Commercial Roadmap
BRIEF

published on 10/17/2024 at 17:45, 1 month 3 days ago

Valbiotis: Ordinary General Meeting of November 5, 2024

Shareholders Liquidity Contract Valbiotis General Assembly Food Supplements
BRIEF

published on 10/15/2024 at 17:45, 1 month 5 days ago

Valbiotis celebrates the success of the INSIGHT study on TOTUM•854

Valbiotis Clinical Study INSIGHT Hypertension TOTUM•854
PRESS RELEASE

published on 10/15/2024 at 17:40, 1 month 5 days ago

Valbiotis announces the major success of the INSIGHT clinical study on TOTUM•854
Valbiotis announces major success of INSIGHT clinical study on TOTUM 854, demonstrating efficacy in reducing systolic blood pressure in individuals with untreated mild hypertension. Validation of innovative plant-based active ingredients

Valbiotis Plant-based INSIGHT Clinical Study TOTUM 854 Systolic Blood Pressure

1 2 ... 5

Accesswire

Published on 11/21/2024 at 10:03, 57 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 25 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 35 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 30 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 55 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 57 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 1 hour ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 1 hour ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 4 hours 2 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 40 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 15 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 15 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE